Wexton and Burgess Lead Bipartisan Letter Urging FDA to Protect Access to Compounded Hormone Therapies
June 21, 2023
June 21, 2023
WASHINGTON, June 21 -- Rep. Jennifer Wexton, D-Virginia, issued the following news release and letter on June 20, 2023:
Today, U.S. Representatives Jennifer Wexton (D-VA) and Michael C. Burgess, M.D. (R-TX) led 23 of their colleagues in sending a bipartisan letter urging the Food and Drug Administration (FDA) to create patient-centered compound hormones policies that maintain patients' access to care and treatment options. Compounded hormone therapies are key in aiding the well . . .
Today, U.S. Representatives Jennifer Wexton (D-VA) and Michael C. Burgess, M.D. (R-TX) led 23 of their colleagues in sending a bipartisan letter urging the Food and Drug Administration (FDA) to create patient-centered compound hormones policies that maintain patients' access to care and treatment options. Compounded hormone therapies are key in aiding the well . . .